Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
9,462.95
9,178.94
8,849.56
8,649.11
7,876.16
6,716.00
6,290.78
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
9,462.95
9,178.94
8,849.56
8,649.11
7,876.16
6,716.00
6,290.78
Raw Material Cost
7,885.88
7,118.41
6,409.23
6,463.18
5,855.80
4,771.03
4,289.06
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
656.08
606.77
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
48.24
45.93
48.70
61.65
69.30
72.93
68.37
Selling and Distribution Expenses
716.79
986.87
1,340.79
1,191.66
1,035.02
1,007.40
1,202.56
Other Expenses
34.59
38.08
41.46
34.03
34.21
-39.38
-40.82
Total Expenditure (Excl Depreciation)
8,996.80
8,531.97
8,213.28
8,056.80
7,302.24
6,113.68
5,758.54
Operating Profit (PBDIT) excl Other Income
466.1
647
636.3000000000001
592.3
573.9
602.3
532.2
Other Income
46.11
71.84
75.83
67.93
85.76
22.55
63.33
Operating Profit (PBDIT)
1,076.66
1,216.07
1,216.93
1,182.07
1,109.86
972.34
890.63
Interest
48.24
45.93
48.70
61.65
69.30
72.93
68.37
Exceptional Items
3.32
-0.08
-6.30
0.00
0.00
0.00
-3.01
Gross Profit (PBDT)
1,577.07
2,060.53
2,440.33
2,185.93
2,020.36
1,944.97
2,001.72
Depreciation
641.89
591.63
574.88
572.32
531.57
433.52
384.12
Profit Before Tax
389.84
578.43
587.05
548.10
508.99
465.90
435.14
Tax
57.06
50.89
29.37
53.10
71.30
72.51
66.08
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
314.39
509.61
548.64
478.02
420.07
365.04
340.14
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
314.39
509.61
548.64
478.02
420.07
365.04
340.14
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
17.80
18.10
10.60
17.50
16.30
25.01
26.25
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
332.19
527.71
559.25
495.51
436.38
390.05
366.39
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.11
1.06
1.1
1.12
1.22
1.19
0.0
Reserves
5,801.58
5,312.11
5,012.99
4,632.73
4,242.21
3,822.26
3,321.14
Earnings per share (EPS)
0.45
0.74
0.8
0.71
0.67
0.59
0.55
Diluted Earnings per share
0.45
0.74
0.8
0.71
0.67
0.59
0.55
Operating Profit Margin (Excl OI)
4.11%
6.02%
6.4%
6.26%
6.25%
7.69%
7.04%
Gross Profit Margin
10.9%
12.75%
13.13%
12.95%
13.21%
13.39%
13.02%
PAT Margin
3.32%
5.55%
6.2%
5.53%
5.33%
5.44%
5.41%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 3.09% vs 3.72% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -37.05% vs -5.63% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -9.94% vs 0.27% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 5.01% vs -5.75% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of Shandong Xinhua Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(HKD)
Change(%)
Net Sales
9,462.95
297.29
9,165.66
3,083.07%
Other Operating Income
0.00
0.00
0.00
Total Operating income
9,462.95
297.29
9,165.66
3,083.07%
Raw Material Cost
7,885.88
57.36
7,828.52
13,648.05%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
184.77
-184.77
-100.00%
Power Cost
0
0
0.00
Manufacturing Expenses
48.24
27.35
20.89
76.38%
Selling and Distribution Expenses
716.79
124.59
592.20
475.32%
Other Expenses
34.59
-6.79
41.38
609.43%
Total Expenditure (Excl Depreciation)
8,996.80
326.12
8,670.68
2,658.74%
Operating Profit (PBDIT) excl Other Income
466.14
-28.83
494.97
1,716.86%
Other Income
46.11
85.36
-39.25
-45.98%
Operating Profit (PBDIT)
1,076.66
79.04
997.62
1,262.17%
Interest
48.24
27.35
20.89
76.38%
Exceptional Items
3.32
0.00
3.32
Gross Profit (PBDT)
1,577.07
239.93
1,337.14
557.30%
Depreciation
641.89
22.51
619.38
2,751.58%
Profit Before Tax
389.84
29.18
360.66
1,235.98%
Tax
57.06
7.78
49.28
633.42%
Provisions and contingencies
0
0
0.00
Profit After Tax
314.39
21.68
292.71
1,350.14%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
314.39
21.68
292.71
1,350.14%
Share in Profit of Associates
0
0
0.00
Minority Interest
17.80
-0.28
18.08
6,457.14%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
332.19
21.40
310.79
1,452.29%
Equity Capital
0
0
0.00
Face Value
1.11
0.00
0.00
Reserves
5,801.58
966.70
4,834.88
500.14%
Earnings per share (EPS)
0.45
0.03
0.42
1,400.00%
Diluted Earnings per share
0.45
0.03
0.42
1,400.00%
Operating Profit Margin (Excl OI)
4.11%
-9.70%
0.00
13.81%
Gross Profit Margin
10.90%
17.39%
0.00
-6.49%
PAT Margin
3.32%
7.29%
0.00
-3.97%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 946.29 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 3.09% vs 3.72% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 33.22 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -37.05% vs -5.63% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 103.05 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -9.94% vs 0.27% in Dec 2024
Annual - Interest
Interest 4.82 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 5.01% vs -5.75% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 4.11%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
